Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e65bad06-247b-447e-9c1f-02afbb58f74d&Preview=1 Date 10/23/2008 Company Name Nora Pharmaceuticals Inc Mailing Address Undisclosed Undisclosed, 90000 Company Description Nora Pharmaceuticals Inc. is a new company formed to develop products for the women’s reproductive-health market. Website Undisclosed Transaction Type Venture Equity Transaction Amount $25,000,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A … Continue reading “Nora Pharmaceuticals Inc Receives $25,000,000 Series A Funding Round”
BaroNova, Inc. Obtains $7,500,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a745e4f4-ab7d-430f-8cd6-0bcb7169b3cb&Preview=1 Date 10/23/2008 Company Name BaroNova, Inc. Mailing Address 2870 Hoy Rd Santa Barbara, CA 93105 Company Description A medical device company focusing on developing innovative nonsurgical, nonpharmacologic therapies for the treatment of obesity. Website http://www.baronova.com Transaction Type Venture Equity Transaction Amount $7,500,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were … Continue reading “BaroNova, Inc. Obtains $7,500,000 Series B Financing Round”
LinkedIn Corporation Secures $22,700,000 Series D Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=68a66d72-a73f-4be1-a15b-145f395afff3&Preview=1 Date 10/23/2008 Company Name LinkedIn Corporation Mailing Address 2029 Stierlin Court Mountain View, CA 94043 Company Description LinkedIn is the leading provider of private and effective networking tools used by over 1.2 million professionals across the globe. By managing their professional network on LinkedIn, users can strengthen and extend their existing … Continue reading “LinkedIn Corporation Secures $22,700,000 Series D Funding Round”
Vulcan’s Healey “Disappointed” in Merck Shutdown, But Says Other Tenants May Fill Void
Vulcan’s Ada Healey got a rude awakening this morning with news on the wires that Merck, one of her company’s main tenants in South Lake Union, is shutting down its Seattle research center to cut costs. Regardless, she says Paul Allen’s real estate portfolio isn’t going to take a serious hit in the neighborhood, and … Continue reading “Vulcan’s Healey “Disappointed” in Merck Shutdown, But Says Other Tenants May Fill Void”
Merck Closing Seattle’s Rosetta Research Center, Cutting 300 Jobs
Merck is leaving Seattle, and cutting 300 local jobs. The Whitehouse Station, NJ-based drug giant said today in its third-quarter earnings report that it is shutting down its Rosetta Inpharmatics research site in Seattle’s South Lake Union neighborhood as part of a global cost-cutting plan to eliminate 7,200 jobs and save as much as $4.2 … Continue reading “Merck Closing Seattle’s Rosetta Research Center, Cutting 300 Jobs”
Helen Greiner Speaks: Next Up After iRobot is Service, Kite-Boarding, and Gearing Up for a New Adventure…in Robotics
Helen Greiner just called me. She didn’t go into any particulars of how or why she came to step down as iRobot’s chairman today, but she did sound upbeat about the next phase of her life—and told me some history about she got hooked on robotics at age 11 and wasn’t about to leave the … Continue reading “Helen Greiner Speaks: Next Up After iRobot is Service, Kite-Boarding, and Gearing Up for a New Adventure…in Robotics”
GE Invested $30M More in A123
GE announced today it invested an additional $30 million in A123Systems, the Watertown, MA-based battery maker. That brings GE’s total investment in A123 to $55 million, or a 9 percent ownership stake. According to the announcement, the $30 million was part of a $102 million Series E round raised by A123 in May, but the … Continue reading “GE Invested $30M More in A123”
Puget Sound Business Journal Launches TechFlash Site with Cook, Bishop
Where are John and Todd? A month after Luke reported that venerable Seattle tech reporters John Cook and Todd Bishop left the Seattle P-I for new roles at the Puget Sound Business Journal, they have officially surfaced today at a new website, called TechFlash. Billed as “Seattle’s technology news source,” TechFlash will offer breaking news … Continue reading “Puget Sound Business Journal Launches TechFlash Site with Cook, Bishop”
IRobot Co-Founder Greiner Resigns as Chair of Board
Updated Oct. 22, 5 pm with comment from company: IRobot co-founder Helen Greiner, who has been instrumental in guiding the company since its inception in 1990 and who has served as a leading voice on robotics innovation worldwide, has resigned as chairman of the company’s board and will be replaced by her fellow co-founder and … Continue reading “IRobot Co-Founder Greiner Resigns as Chair of Board”
Sutus Raises $4.5M, Hires CEO
Sutus, a Vancouver, BC-based telecommunications company, said it has raised $2 million in venture funding from BDC Venture Capital, the Working Opportunity Fund managed by Growthworks Capital, and an additional $2.5 million in debt financing from MMV Financial. The company also hired Mike Donnell as CEO, a 25-year veteran of the software and telecom industries. … Continue reading “Sutus Raises $4.5M, Hires CEO”
Neuroptix Raises $18.5M For Alzheimer’s Diagnostic Test
Neuroptix has raised $18.5 million in a Series B round of venture capital, to push development of a non-invasive eye test that it thinks may be able to diagnose Alzheimer’s disease at its earliest stages. Inventages led the investment round in the Acton, MA-based company, and Rockport Venture Partners acted as the company’s financial advisor. … Continue reading “Neuroptix Raises $18.5M For Alzheimer’s Diagnostic Test”
Amazon Buys Reflexive Entertainment, Looks to Distribute Casual Games
It looks like Amazon is getting more serious about gaming. As we reported in July, the Seattle Internet retail giant backs Atomic Moguls, a Seattle-based social-network gaming firm. Amazon founder and CEO Jeff Bezos is also an investor in Palo Alto, CA-based Social Gaming Network. But now, earlier this week, Reflexive Entertainment, a developer and … Continue reading “Amazon Buys Reflexive Entertainment, Looks to Distribute Casual Games”
SpaceDev Agrees to $38M Acquisition by Nevada Firm
Less than two weeks after the death of its founder, Jim Benson, San Diego-based SpaceDev (OTCBB: [[ticker:SPDV]]) has announced that it’s inked a deal to be acquired by a privately held Nevada firm, Sierra Nevada Corporation (SNC), for $38 million in cash. SpaceDev blasted into the headlines in 2004, when its hybrid rocket engine technology … Continue reading “SpaceDev Agrees to $38M Acquisition by Nevada Firm”
Metaplace Secures $6.7 Million for Virtual Worlds
Metaplace, the open-access virtual world that allows users to build and share their own animated communities, said today that it has collected $6.7 million in new financing, raising the startup’s funding total to $9.4 million. The funding hails from four investors: existing backers Charles River Ventures and Crescendo Ventures, as well as new financiers Ben … Continue reading “Metaplace Secures $6.7 Million for Virtual Worlds”
New EveryZing Video Player Helps Publishers Cash In on Viral Video Distribution
Google’s YouTube makes it incredibly easy to share cool videos with your friends or embed them in your blog or website. The site’s friendliness toward viral distribution is probably why almost every video on the Internet ends up on YouTube sooner or later. But if big companies that publish a lot of Web video leave … Continue reading “New EveryZing Video Player Helps Publishers Cash In on Viral Video Distribution”
Targanta Releases Antibiotic Data
Targanta Therapeutics (NASDAQ:[[ticker:TARG]]) has released detailed data from its Phase 2 study of its antibiotic oritavancin in single or infrequent doses, showing that the fewer doses were as safe and effective as a three-to-seven day course of therapy, according to the Cambridge, MA-based firm. Luke wrote earlier this month about Targanta’s hoped-for FDA approval of … Continue reading “Targanta Releases Antibiotic Data”
VMware Unafraid of MSFT, CEO Says
Seattle Tech Report, a blog published by the Seattle Post-Intelligencer, reports that Paul Maritz, CEO of EMC (NYSE: [[ticker:EMC]]) virtualization subsidiary VMware (NYSE: [[ticker:VMW]]), dismissed Microsoft’s virtualization efforts as a competitive threat in a conference call with analysts yesterday. The company hasn’t seen major losses to Microsoft’s server virtualization products and “we don’t see them … Continue reading “VMware Unafraid of MSFT, CEO Says”
FDA Panel Favors Genzyme’s Myozyme
An FDA panel voted Tuesday in favor of recommending conditional approval of a new version of Cambridge biotech firm Genzyme’s (NASDAQ:[[ticker:GENZ]]) drug alglucosidase alfa (Myozyme) for Pompe disease, according to a report by Bloomberg News. Though the panel’s nod does not guarantee approval of the drug, it puts Genzyme one step closer to marketing a … Continue reading “FDA Panel Favors Genzyme’s Myozyme”
Building New Life Science Companies: The Bob Langer–Terry McGuire Show on Video
One highlight of Xconomy’s September 23 forum, “How to Build a Life Sciences Company,” was my closing chat with MIT Institute Professor and Xconomist Robert Langer and Polaris Venture Partners managing partner Terry McGuire, who have teamed on a long list of local biotech startups. Now, courtesy of the Novartis Institutes for Biomedical Research, which … Continue reading “Building New Life Science Companies: The Bob Langer–Terry McGuire Show on Video”
Gates Foundation Invests in 104 “Untried, Unproven” Ideas for Global Health
The Bill & Melinda Gates Foundation is doling out smaller chunks of cash to spur bigger thinking. The world’s largest private foundation is announcing today it is awarding 104 grants to scientists—at $100,000 apiece—to support off-the-wall ideas that have potential to shake up the conventional wisdom in global health. The Seattle-based foundation hopes to pump … Continue reading “Gates Foundation Invests in 104 “Untried, Unproven” Ideas for Global Health”
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients
ZymoGenetics has some minor good news coming out today. The Seattle biotech company said that a study showed its genetically-engineered protein drug, IL-21, was able to help shrink and stabilize kidney tumors in combination with another targeted drug, even in patients whose disease relapsed after prior therapy. The preliminary results show that three of 18 … Continue reading “ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients”
Antigenics Asks European Regulators to Approve Oncophage for Kidney Cancer
Antigenics, the developer of a personalized treatment to stimulate the immune system to fight tumors, is asking European regulators for permission to sell its vitespen (Oncophage) treatment for kidney cancer. It’s a big step for the New York-based company—which has 90 of its 98 employees in Lexington, MA—on its quest to be the world’s first … Continue reading “Antigenics Asks European Regulators to Approve Oncophage for Kidney Cancer”
Trius Therapeutics Wins $28M Contract From NIH For Bioterror Antibiotics
Trius Therapeutics is on a roll. The San Diego-based biotech company has received a five-year $28 million contract from the National Institutes of Health to develop novel antibiotics against some of the nastiest possible bioterrorism bugs on the planet. Trius will work in a collaboration with researchers at Lawrence Livermore National Laboratory (folks that know … Continue reading “Trius Therapeutics Wins $28M Contract From NIH For Bioterror Antibiotics”
Frontiers of Research on Infectious Diseases
National Academy Member Dr. Guy Palmer of Washington State University and University of Washington Professor Sam Miller, Director of the Northwest Regional Center for Excellence for Biodefense and Emerging Infectious Diseases Research, will show examples of how innovative technology can help us better understand the complexities of infectious disease and how many such diseases arise … Continue reading “Frontiers of Research on Infectious Diseases”
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
There was a lot of activity related to biotech-pharma partnerships this week. That, and the rest of the Boston-area life sciences news, below. —Lexington, MA-based Predictive Biosciences, a diagnostics startup build around research done at Children’s Hospital Boston, raised $21.75 million in Series B financing. New investor New Enterprise Associates led the deal, and Kaiser … Continue reading “Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News”
ManageSoft Corporation Garners $2,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=23fbeb38-8b1f-4248-bab7-65ff0d1a4812&Preview=1 Date 10/22/2008 Company Name ManageSoft Corporation Mailing Address 101 Federal Street 25th Floor Boston, MA 02110 Company Description ManageSoft, The Software Management Company, reduces IT supports costs for desktops, laptops, and servers located anywhere in the world by enabling large organizations to automatically deploy, update and manage software and security patches … Continue reading “ManageSoft Corporation Garners $2,000,000 New Round”
CitySquares Online, Inc. Garners New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f8438d9e-5eca-4d7e-adb9-6eccbfd97f7b&Preview=1 Date 10/22/2008 Company Name CitySquares Online, Inc. Mailing Address 580 Harrison Ave, 4th Floor Boston, MA 02118 Company Description We are most certainly, first and foremost, and undoubtedly about local businesses and local communities. We’re about your neighborhood, and where you get your hair cut, meet your friends for coffee, have … Continue reading “CitySquares Online, Inc. Garners New Funding Round”
Neuroptix, Inc. Obtains $18,500,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aec7c319-7bd5-4dac-ad7e-8f2c72f25e90&Preview=1 Date 10/22/2008 Company Name Neuroptix, Inc. Mailing Address 20 Main Street Acton, MA 01720 Company Description Neuroptix develops, manufactures and distributes state-of-the-art products for extremely sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer’s disease undergoing clinical development. Adaptable and innovative, Neuroptix’s products are … Continue reading “Neuroptix, Inc. Obtains $18,500,000 Series B Financing”
SmartCells, Inc. Secures $1,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7fcad503-ac97-4623-b6e8-b17e7fa55a5e&Preview=1 Date 10/22/2008 Company Name SmartCells, Inc. Mailing Address 100 Cummings Center Beverly, MA 01915 Company Description SmartInsulin™ consists of a layered, biocompatible and biodegradable polymer-therapeutic that is bound to an engineered glucose-binding molecule. Insulin is released from SmartInsulin only when the therapeutic is unbound by the presence of a specific glucose … Continue reading “SmartCells, Inc. Secures $1,000,000 New Funding”
Neurotech Pharmaceuticals Lands $15,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0a9b82f3-4cab-4d10-8cbb-d633cc6f69a4&Preview=1 Date 10/22/2008 Company Name Neurotech Pharmaceuticals Mailing Address 6 Blackstone Valley Place Lincoln, RI 02865 Company Description Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in … Continue reading “Neurotech Pharmaceuticals Lands $15,000,000 Series B Round”
Metaplace Secures $6,700,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6ba367da-5682-41e8-80da-b292dc58f9e1&Preview=1 Date 10/22/2008 Company Name Metaplace Mailing Address Undisclosed San Diego, CA 92121 Company Description Metaplace is the world’s first open platform that harnesses the power of the Web to allow anyone to create, build and live in their own unique virtual world. Our vision is to enable users to build a … Continue reading “Metaplace Secures $6,700,000 Series B Financing Round”
AudioMicro.com Inc Obtains Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94be2d2f-7c27-4014-a644-be856781b7a7&Preview=1 Date 10/22/2008 Company Name AudioMicro.com Inc Mailing Address 4550 Fulton Ave Sherman Oaks, CA 91423 Company Description AudioMicro is a revolutionary collection of user-generated micro stock music, sound effects, production music, production elements and music cues. Finally, high quality audio content is available at unbelievable prices with no hidden costs or … Continue reading “AudioMicro.com Inc Obtains Series A Funding”
A123Systems Obtains $30,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8465c7b0-edf8-4757-b1ad-65792f743c25&Preview=1 Date 10/22/2008 Company Name A123Systems Mailing Address 321 Arsenal Street Watertown, MA 02472 Company Description A123Systems is the developer of a new generation of Lithium-ion batteries that deliver previously unattainable power levels, safety and life to a wide range of applications. Website http://www.a123systems.com/ Transaction Type Venture Equity Transaction Amount $30,000,000 Transaction … Continue reading “A123Systems Obtains $30,000,000 New Funding”
AdMob Lands $15,700,000 Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=109314cc-cb1b-441c-8c1f-176a30eb6aeb&Preview=1 Date 10/22/2008 Company Name AdMob Mailing Address 60 East 3rd Avenue San Mateo, CA 94401 Company Description AdMob is the world’s largest mobile advertising marketplace. Founded in 2006, AdMob allows advertisers to reach their customers on the mobile Web and publishers to increase the value of their mobile sites through advertising. … Continue reading “AdMob Lands $15,700,000 Series C Funding”
SiliconBlue Technologies Corporation Lands $24,000,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b20c6202-a90b-4e10-8631-286a8c1d4f7a&Preview=1 Date 10/22/2008 Company Name SiliconBlue Technologies Corporation Mailing Address 3255 Scott Blvd. Bld. 7 Santa Clara, CA 95054 Company Description SiliconBlue has built from ground up, the first single-chip, reprogrammable, ultra-low power FPGA optimized for handheld, mobile applications. Website http://www.siliconbluetech.com Transaction Type Venture Equity Transaction Amount $24,000,000 Transaction Round Series B … Continue reading “SiliconBlue Technologies Corporation Lands $24,000,000 Series B Funding Round”
Envia Systems Lands $3,200,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51a13254-a7f4-4703-be7b-359665c25be0&Preview=1 Date 10/22/2008 Company Name Envia Systems Mailing Address 26138 Research Road Hayward, CA 94545 Company Description Envia Systems is a technology leader in high performance, low cost energy storage solutions using lithium ion batteries. Our disruptive products will enable widespread adoption of clean energy applications such as electric vehicles, hybrid electric … Continue reading “Envia Systems Lands $3,200,000 Series A Funding Round”
Like.com Secures $32,000,000 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=81122ecb-b799-4070-84ad-93073e662a04&Preview=1 Date 10/22/2008 Company Name Like.com Mailing Address 777 Mariner’s Island Blvd. San Mateo, CA 94404 Company Description Like.com is the first true visual search engine, where the contents of photos are used to search and retrieve similar items. We believe that there are literally millions of items that are difficult to … Continue reading “Like.com Secures $32,000,000 Series C Funding Round”
Diabetes Research: Participation Critical
The American Diabetes Association, Washington Biotechnology & Biomedical Association and Northwest Association for Biomedical Research invite you to be a “Research Hero.” Learn about the frontiers of diabetes research and the heroes, including volunteers in clinical trials, who are making advancements toward better treatment, better prevention, and the hope of a cure. Speakers include Paul … Continue reading “Diabetes Research: Participation Critical”
Last Day to Take the Financial Crisis Survey
Two weeks ago, the Washington Technology Industry Association launched a survey to get feedback from the tech community about the current financial crisis and its impact on businesses. Xconomy is the WTIA’s exclusive media partner for the survey, and we plan to report its findings next week. The survey is scheduled to close by the … Continue reading “Last Day to Take the Financial Crisis Survey”
Bellingham Pioneer of ‘Ultra Rice’ Wins Business Week Innovation Honor—Except They Didn’t Name Him
Duffy Cox isn’t a one-hit wonder with “Ultra Rice.” The Bellingham, WA-based inventor, who has worked to fortify rice with essential nutrients for people in developing countries, has been honored by Business Week for his work to pasteurize eggs while they’re still in the shells. Cox and his company, Bon Dente International, don’t get the … Continue reading “Bellingham Pioneer of ‘Ultra Rice’ Wins Business Week Innovation Honor—Except They Didn’t Name Him”
Amylin Gets $125M from Eli Lilly To Make Once-Weekly Diabetes Drug
Amylin Pharmaceuticals said today it has scored a $125 million cash payment from Eli Lilly to manufacture a once-weekly injectable version of exenatide for diabetes. The San Diego-based biotech company will also get a $165 million line of credit from Lilly, which it can draw upon starting in the fourth quarter of 2009 through the … Continue reading “Amylin Gets $125M from Eli Lilly To Make Once-Weekly Diabetes Drug”
Tech Advice for the Next U.S. President: Seattle and Boston Leaders Weigh In
Whether it’s John McCain or Barack Obama, what should the new American president do to promote technological innovation and global competitiveness? Computerworld asked a collection of tech luminaries from around the country for their advice, and published their thoughts today. Here are contributions from three info-tech experts in Xconomy cities. Rick Rashid, senior vice president … Continue reading “Tech Advice for the Next U.S. President: Seattle and Boston Leaders Weigh In”
Tech Coast Angels Funds Startup Developing Ultra-Low Power Wireless Video
San Diego-based MicroPower Appliance has received an undisclosed amount of Series A funding from Tech Coast Angels to help support its development of a battery-powered, Wi-Fi video camera. According to Mike Elconin, the San Diego network president of Tech Coast Angels, ultra-low powered, wireless video cameras have a number of potential applications, with Internet-based video … Continue reading “Tech Coast Angels Funds Startup Developing Ultra-Low Power Wireless Video”
Earth Class Mail Raises $5.1M
Seattle-based Earth Class Mail, which digitizes paper mail and delivers it via the Internet, has announced it has raised $5.1 million in angel investment led by Keiretsu Forum. Earth Class Mail also said it has increased staffing by 35 percent in the past two quarters to keep up with demand from corporate and government customers.
Bayer Buys License to ImmunoGen Cancer Drug Technology
ImmunoGen, a Waltham, MA-based drug developer, said today that Bayer has obtained an exclusive worldwide license to its Tumor-Activated Prodrug technology, which allows a drug to remain safe and stable in the blood, and then release a cell-killing agent when it gets inside tumors. ImmunoGen (NASDAQ: [[ticker:IMGN]]) will get $4 million upfront, plus milestone payments … Continue reading “Bayer Buys License to ImmunoGen Cancer Drug Technology”
Symbian OS Gets Skyhook Location System
Back in January, Boston’s Skyhook Wireless scored a huge win by getting its Wi-Fi Positioning System (WPS)—which helps cellphones and laptops determine their locations by listening for nearby wireless hotspots—into the Apple iPhone. And every few weeks since then I’ve gotten another note from Skyhook, saying that WPS or its hybrid GPS/Wi-Fi/cellular-based cousin, XPS, has … Continue reading “Symbian OS Gets Skyhook Location System”
Akamai Buys Acerno, Adds Targeted Advertising Capability
Akamai, the Cambridge, MA-based operator of Internet content distribution networks, today released news that it will acquire Acerno, a New York- and San Francisco-based targeted-advertising company, for $95 million in cash. The move gets Akamai (NASDAQ: [[ticker:AKAM]]) into the increasingly popular game of “behavioral targeting,” or serving specific ads to online shoppers based on their … Continue reading “Akamai Buys Acerno, Adds Targeted Advertising Capability”
A Student Entrepreneur in Paradise
On Saturday, I attended the 2nd annual Elevator Pitch Competition (EPC) at MIT—the first leg of the year-long MIT $100K Business Plan Competition. The EPC is all about generating ideas, and over the action-packed day, culminating in an amazing, Rocky-themed finale in the evening, I had the opportunity to hear a lot of them. The … Continue reading “A Student Entrepreneur in Paradise”
CheapFlights Founders Launch Retro Deals Site CheapToday
At a time of dwindling portfolios, mass layoffs, impending recession, and general financial queasiness, Web entrepreneurs should to go back to basics, focusing on services that help customers save money, say startup gurus like Paul Graham. That’s exactly what CheapToday did last week, launching a website and an e-mail newsletter that highlight the best deals … Continue reading “CheapFlights Founders Launch Retro Deals Site CheapToday”
Pervasis, Maker of Product to Heal Blood Vessels, Hires Genzyme Exec as First CEO
Pervasis Therapeutics, a Cambridge, MA-based cell therapy company, has hired a veteran businessman from Genzyme as its first CEO. Frederic Chereau, a former vice president and general manager of the cardiovascular business unit of Genzyme, takes over a company that aims to create a cell-based product that will help stop excessive inflammation and promote healing. … Continue reading “Pervasis, Maker of Product to Heal Blood Vessels, Hires Genzyme Exec as First CEO”